PHKB activators encompass a diverse group of chemicals that potentially modulate the expression or activity of the Phosphorylase kinase regulatory subunit beta (PHKB), a key component in the phosphorylase kinase (PhK) complex involved in glycogen metabolism. These activators may operate through various molecular mechanisms, such as influencing transcriptional regulation, protein stability, and enzymatic activity. Histone deacetylase inhibitors and DNA methyltransferase inhibitors are examples of compounds that might enhance PHKB expression by promoting a more open chromatin structure, facilitating gene transcription. Similarly, modulators of cellular signaling pathways, like mTOR pathway inhibitors and cAMP elevating agents, could indirectly impact PHKB expression by influencing a network of cellular processes and regulatory pathways related to energy metabolism and cellular homeostasis.
The specificity and mechanisms of action of PHKB activators are subjects of ongoing scientific exploration. The goal is to elucidate the precise molecular interactions and effects of these activators on PHKB and related components of glycogen metabolism pathways. A nuanced understanding of these processes is crucial to appreciate the multifaceted roles of PHKB in cellular physiology and metabolism. Through careful research and investigation, the scientific community aims to unravel the complexities of PHKB regulation and the potential influences of various chemical activators in modulating its expression and function within the broader context of glycogen metabolism and cellular energy homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
HDAC inhibitor that can increase gene expression by promoting a more open chromatin structure, possibly enhancing PHKB transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Another HDAC inhibitor with similar potential mechanisms as Valproic acid. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methyltransferases, potentially demethylating the PHKB promoter and enhancing its transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Similar to 5-Azacytidine, it's a DNA methyltransferase inhibitor that might demethylate and activate the PHKB gene. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $128.00 $638.00 | 7 | |
Similar to Rapamycin, it's an mTOR pathway inhibitor with potential indirect effects on PHKB expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activator of Protein Kinase C which might, through downstream signaling, affect PHKB expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
An antioxidant that can activate sirtuins and might have effects on gene expression regulation, potentially including PHKB. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
A polyphenol that has various effects on signaling pathways. Its broad effects on cellular signaling might indirectly modulate PHKB expression. | ||||||